Medical News

RSS

If you suffer from sleep apnea, consult with your dentist: PDA

Sleep apnea, a serious and potentially life-threatening disorder if left untreated, affects approximately 18 million Americans. During sleep apnea episodes, a person stops breathing for at least 10 seconds. Depending on the severity of the disorder, a person can have between 10 and 60 episodes a night. Sleep apnea treatment often involves a team of healthcare providers, including dentists, general physicians, surgeons and sleep specialists.

18 Jun 2010

Children's Hospital of Philadelphia first in region to implant transcatheter pulmonary heart valves

Signaling a new frontier in the treatment of congenital heart disease (CHD), The Children's Hospital of Philadelphia is the first hospital in our region to implant transcatheter pulmonary heart valves in children with heart defects. This minimally invasive procedure gives patients a non-surgical option in their ongoing treatment.

18 Jun 2010

Researchers make significant headway in fight against SMA

Researchers at the University of Utah are making strides in understanding and combating a motor neuron disease known as Spinal Muscular Atrophy. The spinal muscular atrophies are a group of inherited diseases that cause progressive degeneration of motor nerves resulting in muscle weakness. The most common form of the disorder, due to the deletion of a critical gene on chromosome 5, is currently the leading cause of inherited infant and child mortality.

18 Jun 2010

An ubiquitin-specific peptidase that potentially promote cancer cell necrosis

"ubiquitin-specific peptidase 21 (USP21) has been identified as another essential player in regulation of tumor necrosis factor alpha (TNF-alpha)-induced nuclear factor kappaB (NF-kappaB) activation by working on receptor-interacting protein 1(RIP1)."

18 Jun 2010

IMGM acquires 3,100,000 Class B Preferred Shares of Positron

The Shareholders of Imagin Molecular Corporation ("IMGM") have approved, through a consent of over 51% of shareholder vote, certain transactions wherein IMGM completed the acquisition of 3,100,000 Class B Preferred Shares of Positron Corporation which shares are convertible on a 1 for 100 basis into Positron common shares.

18 Jun 2010

Laboratory mouse study shows cold sensing neural circuits develop well after birth

Cold sensing neural circuits in newborn mice take around two weeks to become fully active, according to a new study. The finding adds to understanding of the cold sensing protein TRPM8 (pronounced trip-em-ate), first identified in a Nature paper in 2002 by David McKemy of the University of Southern California.

18 Jun 2010

Gary Coleman's death highlights importance of end-of-life decisions

Actor Gary Coleman's death is highlighting the importance of who makes your end-of-life decisions and is drawing attention to the fact that having a "living will" does not always guarantee that your wishes will be carried out, CNN reports.

18 Jun 2010

U.S. officials announce new agriculture research initiative to aid farmers in developing countries

Citing USAID's Feed the Future initiative as "central" to U.S. foreign policy, Secretary of State Hillary Rodham Clinton on Wednesday announced plans to "leverage the work" of U.S. researchers to "benefit farmers in developing countries worldwide," PTI/The Hindu reports.

18 Jun 2010

NMT Medical receives preliminary results for CLOSURE I PFO/stroke and transient ischemic attack trial

NMT Medical, Inc., an advanced medical technology company that designs, develops, manufactures and markets proprietary implant technologies that allow interventional cardiologists to treat structural heart disease through minimally invasive, catheter-based procedures, today announced that it has received preliminary results for CLOSURE I, its patent foramen ovale (PFO)/stroke and transient ischemic attack (TIA) trial in the U.S.

18 Jun 2010

Transdel, JMSR enter into licensing agreement

Transdel Pharmaceuticals, Inc. and Jan Marini Skin Research, Inc. have entered into a licensing agreement providing JMSR with the exclusive U.S. rights to Transdel's transdermal delivery technology for use in an anti-cellulite cosmeceutical product for the dermatological market.

18 Jun 2010

CLEAR study meets primary endpoint: Sorin Group

Sorin Group, a global leader in the treatment of cardiovascular diseases, announced today that the CLEAR study has met its primary endpoint.

18 Jun 2010

Mount Sinai School of Medicine, Alnylam collaborate to develop microRNA-based attenuated influenza viruses

Mount Sinai School of Medicine has completed an exclusive option agreement with Alnylam Pharmaceuticals, Inc. a leading RNAi therapeutics company, for intellectual property related to RNAi applications in vaccine development. These new applications of RNAi technology define opportunities for the advancement of novel vaccines in infectious disease.

18 Jun 2010

Maternal, infant ART drives down mother-to-child HIV transmission through breast-feeding, studies show

According to two new studies, "giving pregnant and nursing women triple antiretroviral drug therapy, or treating breast-fed infants with an antiretroviral medication, can dramatically cut transmission rates, enabling moms to both breast-feed and to protect nearly all children from infection," HealthDay News/Bloomberg Businessweek reports (Goodwin, 6/16).

18 Jun 2010

Baylor University researchers awarded grant to research and test new compounds for cancer

The National Institutes of Health has awarded two Baylor University researchers a $1.46 million grant to research and test new compounds that could help fight cancerous tumors.

18 Jun 2010

Drug makers face tightened regulations by FDA and less clout at medical meetings

The Washington Post: "The Food and Drug Administration this week began posting online the results of safety evaluations of recently approved drugs and vaccines. The action follows a law enacted in 2007 that requires the agency to provide more safety information to consumers and health professionals. The evaluations must be conducted 18 months after a new drug comes on the market.

18 Jun 2010

Elderly people in sub-Saharan Africa remain neglected as a result of AIDS epidemic: Researchers

The rise in AIDS death rates in sub-Saharan Africa has led to a burgeoning new category of neglected individuals - nearly a million orphaned elderly, or older adults living alone without the benefit of any caregivers, Stanford University School of Medicine researchers have found.

18 Jun 2010

Paternal involvement in pregnancy reduces infant deaths

Studies have shown fathers who are active in their children's upbringing can significantly benefit their children's early development, academic achievement and well being. Now, a new study by University of South Florida researchers suggests that a father's involvement before his child is born may play an important role in preventing death during the first year of life - particularly if the infant is black.

18 Jun 2010

Loss of Manhattan hospital crowds other ERs; Utah discourages Medicaid patients from unnecessary ER visits

"Emergency rooms in downtown Manhattan have become more crowded since St. Vincent's Hospital closed in April, but ambulances are getting patients into the remaining ERs faster than they did when the 161-year-old Greenwich Village hospital was open." Bellevue Hospital Center, Beth Israel Medical Center, New York Downtown Hospital and New York University Langone Medical Center are the "four downtown ERs left to pick up the slack" and have experienced increases in patient visits in May compared with 2008 levels.

18 Jun 2010

Medical Simulation announces new agreement with New York's North Shore-LIJ Health System

Medical Simulation Corporation (MSC) proudly announces a new agreement with the North Shore-LIJ Health System, New York's largest health system and recipient of the 2010 National Quality Healthcare Award from the National Quality Forum. The agreement includes the sale of MSC's endovascular simulation system, Simantha®, and licensing of MSC's curriculum and training services to advance North Shore's education and patient safety goals over the next three years.

18 Jun 2010

Possible mechanism identified for how lithium treats bipolar disorder

Lithium has been established for more than 50 years as one of the most effective treatments for manic depression, clinically termed bipolar disorder. However, scientists have never been entirely sure exactly why it is beneficial.

18 Jun 2010

Medical News

If you suffer from sleep apnea, consult with your dentist: PDA

Children's Hospital of Philadelphia first in region to implant transcatheter pulmonary heart valves

Researchers make significant headway in fight against SMA

An ubiquitin-specific peptidase that potentially promote cancer cell necrosis

IMGM acquires 3,100,000 Class B Preferred Shares of Positron

Laboratory mouse study shows cold sensing neural circuits develop well after birth

Gary Coleman's death highlights importance of end-of-life decisions

U.S. officials announce new agriculture research initiative to aid farmers in developing countries

NMT Medical receives preliminary results for CLOSURE I PFO/stroke and transient ischemic attack trial

Transdel, JMSR enter into licensing agreement

CLEAR study meets primary endpoint: Sorin Group

Mount Sinai School of Medicine, Alnylam collaborate to develop microRNA-based attenuated influenza viruses

Maternal, infant ART drives down mother-to-child HIV transmission through breast-feeding, studies show

Baylor University researchers awarded grant to research and test new compounds for cancer

Drug makers face tightened regulations by FDA and less clout at medical meetings

Elderly people in sub-Saharan Africa remain neglected as a result of AIDS epidemic: Researchers

Paternal involvement in pregnancy reduces infant deaths

Loss of Manhattan hospital crowds other ERs; Utah discourages Medicaid patients from unnecessary ER visits

Medical Simulation announces new agreement with New York's North Shore-LIJ Health System

Possible mechanism identified for how lithium treats bipolar disorder

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Latest News